Nexalin Technology NXL
NASDAQ NXL
$4.85 -0.20 (-3.84%)
As of: Sep 10, 2026 · 12:03 PM EDT

Nexalin Technology (NXL) Profit After Tax (2021 - 2026)

Nexalin Technology (NXL) posted Profit After Tax of -$2.2 million for Q2 2026, down 6.81% on a QoQ basis from -$2.1 million in Q1 2026, and down 41.66% year-over-year from -$3.8 million in Q2 2025.

Analysis

Nexalin Technology (NXL) Profit After Tax (2021 - 2026) Analysis & Trends

Nexalin Technology has reported Profit After Tax for 6 years, with the latest figure at -$2.2 million in Q2 2026.

  • On a quarterly basis, Profit After Tax fell 41.66% year-over-year to -$2.2 million in Q2 2026; TTM through Jun 2026 was -$9.0 million, a 1.57% decrease from a year earlier, with the FY2025 full-year figure at -$8.2 million, down 8.08% from the prior year.
  • Profit After Tax was -$2.2 million for Q2 2026 at Nexalin Technology, down from -$2.1 million in the prior quarter.
  • The five-year high for Profit After Tax was -$135401.0 in Q3 2022, with the low at -$2.8 million in Q4 2024.
  • Average Profit After Tax over 5 years is -$1.5 million, with a median of -$1.4 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2023: Profit After Tax jumped 92.48% in 2022, then plunged 1620.43% in 2023.
  • Over 5 years, Profit After Tax stood at -$729677.0 in 2022, then fell by 7.15% to -$781874.0 in 2023, then plunged by 262.38% to -$2.8 million in 2024, then gained by 16.13% to -$2.4 million in 2025, then increased by 5.76% to -$2.2 million in 2026.
  • The last three Profit After Tax figures came in at -$2.2 million (Q2 2026), -$2.1 million (Q1 2026), and -$2.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Abbott Laboratories 180.78 Bn 175.17 Bn 7.27 Bn 928.00 Mn
2 Intuitive Surgical 127.04 Bn 121.82 Bn 1.96 Bn 823.20 Mn
3 Medtronic 117.04 Bn 108.22 Bn 6.34 Bn 1.48 Bn
4 Stryker 103.86 Bn 100.38 Bn 4.50 Bn 1.28 Bn
5 Boston Scientific 63.50 Bn 62.96 Bn 3.85 Bn 905.00 Mn
6 Edwards Lifesciences 49.74 Bn 45.49 Bn 1.35 Bn 241.90 Mn
7 Alcon 32.99 Bn 31.53 Bn 1.68 Bn -
8 Dexcom 32.12 Bn 30.17 Bn 830.00 Mn 249.10 Mn
9 Steris 20.69 Bn 20.21 Bn 684.20 Mn 201.00 Mn
10 Nexalin Technology 3.42 Mn 2.41 Mn 8,897.00 -2.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.24 Mn
Mar 31, 2026 -2.10 Mn
Dec 31, 2025 -2.38 Mn
Sep 30, 2025 -2.28 Mn
Jun 30, 2025 -1.58 Mn
Mar 31, 2025 -1.99 Mn
Dec 31, 2024 -2.83 Mn
Sep 30, 2024 -2.45 Mn
Jun 30, 2024 -1.28 Mn
Mar 31, 2024 -1.04 Mn
Dec 31, 2023 -781,874.00
Sep 30, 2023 -2.33 Mn
Jun 30, 2023 -830,417.00
Mar 31, 2023 -748,414.00
Dec 31, 2022 -729,677.00
Sep 30, 2022 -135,401.00
Jun 30, 2022 -462,405.00
Mar 31, 2022 -393,249.00
Dec 31, 2021 -595,928.00
Sep 30, 2021 -1.80 Mn